Among these DEGPeps, 7 and 3 site-specific fucosylated glycopeptides from IgA1 and IgG2, showed a directionally concerted up-regulation in the HC-CHB-LC-HCC progression (Fig. 7A). The gene discussed is IGHA1; the disease is hepatocellular carcinoma.